Article Details
Retrieved on: 2025-03-03 20:26:09
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Joshua R. Disbrow, Chief Executive Officer of AYTU BIOPHARMA, purchased 15000 shares of common stock on February 28, 2025, at a weighted average ...
Article found on: www.tradingview.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here